Evidence map›Paper›PMID 35870449›Full record

ArticleCell2022

Large-scale multiplexed mosaic CRISPR perturbation in the whole organism.

Bo Liu, Zhengyu Jing, Xiaoming Zhang, Yuxin Chen, Shaoshuai Mao, Ravinder Kaundal, Yan Zou, Ge Wei, Ying Zang, Xinxin Wang and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Ablation of dysmorphic neurons is a safe and effective treatment for focal cortical dysplasia II.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  6. Article
  7. CRISPR-based functional genomics tools in vertebrate models.Experimental & molecular medicine · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Pooled screening with next-generation gene editing tools.Current opinion in biomedical engineering · 2023
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Clonal hematopoiesis and bone marrow inflammation.Translational research : the journal of laboratory and clinical medicine · 2023
    Review
  20. Deletion ofJournal of thoracic disease · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Bo LiuGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Zhengyu JingGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Xiaoming ZhangGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Yuxin ChenGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Shaoshuai MaoGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Ravinder KaundalDepartment of Immunobiology, Yale University Medical School, New Haven, CT 06520, USA.
Yan ZouGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Ge WeiGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Ying ZangGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Xinxin WangGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Wenyang LinGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Minghui DiGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Yiwen SunGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Qin ChenGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Yongqin LiGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Jing XiaGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Jianlong SunGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Chao-Po LinGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Xingxu HuangGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.
Tian ChiGene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China; Department of Immunobiology, Yale University Medical School, New Haven, CT 06520, USA. Electronic address: chitian@shanghaitech.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we report inducible mosaic animal for perturbation (iMAP), a transgenic platform enabling in situ CRISPR targeting of at least 100 genes in parallel throughout the mouse body. iMAP combines Cre-loxP and CRISPR-Cas9 technologies and utilizes a germline-transmitted transgene carrying a large array of individually floxed, tandemly linked gRNA-coding units. Cre-mediated recombination triggers expression of all the gRNAs in the array but only one of them per cell, converting the mice to mosaic organisms suitable for phenotypic characterization and also for high-throughput derivation of conventional single-gene perturbation lines via breeding. Using gRNA representation as a readout, we mapped a miniature Perturb-Atlas cataloging the perturbations of 90 genes across 39 tissues, which yields rich insights into context-dependent gene functions and provides a glimpse of the potential of iMAP in genome decoding.

Indexed as

CRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsAnimalsGene EditingGenomeMiceTransgenesRNA, Guide, CRISPR-Cas SystemsCAR Tcell atlasimmunotherapyin vivo CRISPR screenmouse cell Perturb-AtlasPerturb-seq

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.